Results 81 to 90 of about 7,354 (172)

Abstract

JPGN Reports, Volume 6, Issue S2, Page S1-S814, September 2025.
wiley   +1 more source

295 CFTR-R933 mutations reduce channel opening but still permit potentiation by ivacaftor

, 2023
Wenxian Wang, Lianwu Fu, C. Martin, S. Rowe, Stephen G. Aller   +4 more
openalex   +1 more source

Urticaria multiforme-like eruption due to a novel agent elexacaftor/tezacaftor/ivacaftor in a pediatric patient with cystic fibrosis

, 2021
Rebecca H. Goldberg, Natalie H. Matthews, Alexandra C. Hristov, Frank Wang   +3 more
openalex   +1 more source

Lumacaftor-ivacaftor in the treatment of cystic fibrosis: design, development and place in therapy

Drug Design, Development and Therapy, 2019
GJ ConnettNational Institute for Health Research, Southampton Respiratory Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UKAbstract: Lumacaftor-ivacaftor is a combination of two small molecule ...
Connett GJ
doaj  

ICER releases evidence report on elexacaftor/tezacaftor/ivacaftor for cystic fibrosis [PDF]

, 2020

openalex   +1 more source

WS07.4 Effect of ivacaftor on airway bacterial community composition in CF patients with the G551D mutation

, 2016
D. Mooney, N.J. Ronan, G.G. Einarsson, E.T. Flanagan, J.A. Eustace, Michael M. Tunney, J.S. Elborn, B.J. Plant   +7 more
openalex   +1 more source

WS18.1 Combination FDL169/FDL176 is superior to tezacaftor/ivacaftor

, 2017
B. Cole, Praghnesh Bhatt, Immanuel Kwok, V. Bailey, W. An, C. Bresilla, J. Chin, Mauri E. Krouse   +7 more
openalex   +1 more source

144 Effect of treatment with ivacaftor on exhaled nitric oxide

, 2015
Hartmut Grasemann, Tanja Gonska, Julie Avolio, Elizabeth Tullis, Félix Ratjen   +4 more
openalex   +1 more source

430 Ivacaftor treatment decreases prevalence of insoluble mucus flakes in young people with cystic fibrosis

, 2022
M. Markovetz, W. Boone, K. Rouillard, S. Stick, Christopher P. Esther, D. Hill   +5 more
openalex   +1 more source

Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis [PDF]

Ryan Marsh, Claudio Dos Santos, Alexander Yule, Neele Dellschaft, Caroline L. Hoad, Christabella Ng, Giles Major, Alan R Smyth, Damian Rivett, Chris Gast   +9 more
openalex   +2 more sources